BridgeMD
Detect GHB
EU CTIS ID: 2022-501329-18-00
What this study is testing
The primary objective is to investigate whether one or more of the identified potential biomarkers can be detected longer than GHB itself in blood.
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Healthy volunteers aged 18-65 years
- Informed, written consent
- Able to understand Danish
You likely can't join if
- Current or previous substance abuse or alcohol abuse
- A psychiatric disorder that requires medical treatment, incl. major depression
- Pregnant and breastfeeding women (Fertile women (defined as amenorrhea for less than 12 months) must have a negative HCG pregnancy test prior to intake of the trial medication)
- Current or previous treatment with GHB
- Treatment with valproate or topiramate
- Treatment with benzodiazepines, opioids, or another CNS-depressant medicinal product
See the full eligibility criteria
- Healthy volunteers aged 18-65 years
- Informed, written consent
- Able to understand Danish
- Current or previous substance abuse or alcohol abuse
- A psychiatric disorder that requires medical treatment, incl. major depression
- Pregnant and breastfeeding women (Fertile women (defined as amenorrhea for less than 12 months) must have a negative HCG pregnancy test prior to intake of the trial medication)
- Current or previous treatment with GHB
- Treatment with valproate or topiramate
- Treatment with benzodiazepines, opioids, or another CNS-depressant medicinal product
- Hypersensitive to sodium oxybate or any of the excipients of Sodium Oxybate (i.e. malic acid and sodium hydroxide)
- Succinic semialdehyde dehydrogenase deficiency
- History of impaired hepatic or renal function
- A diagnosis of epilepsy
- A diagnosis of porphyria
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.